The phrase 'lower triglycerides' refers to reducing triglycerides – a type of blood fat used for energy storage. Elevated levels (hypertriglyceridemia) are a risk factor for cardiovascular disease and are often linked to obesity, high sugar intake, alcohol, or genetic factors. A DNA test like MyBody-X can identify single gene variants (e.g., in APOA5 or LPL) that influence triglyceride metabolism. However, the clinical utility of such single-SNP analysis is limited: most triglyceride variation is polygenic and heavily driven by lifestyle. MyBody-X does not directly measure blood triglycerides; it only offers genetic risk assessments. The evidence that these tests meaningfully improve health outcomes is weak and largely marketing-based. To actually lower triglycerides, the primary strategies are a Mediterranean diet, reducing sugar and alcohol, and regular exercise. A doctor’s visit with a blood panel is essential before any interpretation. So, 'lower triglycerides' in the context of a DNA test means: clues about genetic predisposition, but not a diagnosis or direct action plan.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-9f3e60ffb38595c1747fd75a